These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34676643)
1. Efficacy and safety of botulinum toxin injection in reducing deltoid muscle hypertrophy. Shin SH; Park SJ; Yeoum SH; Youn CS; Park KY Dermatol Ther; 2021 Nov; 34(6):e15168. PubMed ID: 34676643 [TBL] [Abstract][Full Text] [Related]
2. A Double-Blinded, Randomized, Dose-Comparison Pilot Study to Comparatively Evaluate Efficacy and Safety of Two Doses of Botulinum Toxin Type A Injection for Deltoid Muscle Hypertrophy. Koh YG; Shin SH; Kim KR; Yeoum SH; Choi WW; Park KY Ann Dermatol; 2023 Oct; 35(5):355-359. PubMed ID: 37830417 [TBL] [Abstract][Full Text] [Related]
3. Botulinum neurotoxin injection in the deltoid muscle: application to cosmetic shoulder contouring. Yi KH; Lee JH; Hu H; Park HJ; Lee HJ; Choi YJ; Kim HJ Surg Radiol Anat; 2023 Jul; 45(7):875-880. PubMed ID: 37178218 [TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, open-label comparative study of prabotulinumtoxinA with two different dosages and diverse proportional injection styles for the reduction of gastrocnemius muscle hypertrophy in Asian women. Suh Y; Jeong GJ; Noh H; Sun S; Hwang CH; Oh TS; Kim BJ Dermatol Ther; 2019 Sep; 32(5):e13009. PubMed ID: 31251444 [TBL] [Abstract][Full Text] [Related]
5. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment. Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Botulinum Toxin Type A Injection in Patients with Bilateral Trapezius Hypertrophy. Zhou RR; Wu HL; Zhang XD; Ye LL; Shao HJ; Song XH; Song ML; Zheng SS Aesthetic Plast Surg; 2018 Dec; 42(6):1664-1671. PubMed ID: 30206648 [TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Botulinum Toxin A Injection for Gastrocnemius Hypertrophy: A Prospective, Randomized, Double-blinded Controlled Trial. Han WY; Lee YS; Han HH Plast Reconstr Surg Glob Open; 2024 May; 12(5):e5813. PubMed ID: 38798944 [TBL] [Abstract][Full Text] [Related]
8. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring. Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA; Fallico N; Mazzocchi M; Scuderi N Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of a Novel Botulinum Toxin A for Masseter Reduction: A Randomized, Double-Blind, Placebo-Controlled, Optimal Dose-Finding Study. Hong JY; Jeong GJ; Kwon TR; Kim JH; Li K; Kim BJ Dermatol Surg; 2021 Jan; 47(1):e5-e9. PubMed ID: 33347002 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A treatment for contouring of the lower face. Park MY; Ahn KY; Jung DS Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A in the management of masseter muscle hypertrophy. Castro WH; Gomez RS; Da Silva Oliveira J; Moura MD; Gomez RS J Oral Maxillofac Surg; 2005 Jan; 63(1):20-4. PubMed ID: 15635552 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring. Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198 [TBL] [Abstract][Full Text] [Related]
14. The Volumetric Effect of Botulinum Toxin Type A Injection on the Parotid Gland: A Randomized Controlled Trial. Jeong WS; Hong DW; Ahn TJ; Han HH Plast Reconstr Surg; 2024 Feb; 153(2):337-343. PubMed ID: 37010458 [TBL] [Abstract][Full Text] [Related]
15. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A]. Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323 [TBL] [Abstract][Full Text] [Related]
16. A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: a retrospective, open-label chart review. Lang AM Clin Ther; 2003 Aug; 25(8):2268-78. PubMed ID: 14512133 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. To EW; Ahuja AT; Ho WS; King WW; Wong WK; Pang PC; Hui AC Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study. Seok J; Koh YG; Hong JK; Yun SH; Kim DH; Son HS; Choi SY; Yoo KH; Lee YW; Kim BJ Dermatol Surg; 2024 Jun; 50(6):527-533. PubMed ID: 38518110 [TBL] [Abstract][Full Text] [Related]
19. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness? Park G; Choi YC; Bae JH; Kim ST Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291 [TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin Injections for Leg Contouring in East Asians. Cheng J; Chung HJ; Friedland M; Hsu SH Dermatol Surg; 2020 Oct; 46 Suppl 1():S62-S70. PubMed ID: 31977500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]